Generation and characterization of genetically and antigenically diverse infectious clones of dengue virus serotypes 1–4

References

• Wilder-Smith A, Renhorn KE, Tissera H, et al. Denguetools: innovative tools and strategies for the surveillance and control of dengue. Glob Health Action. 2012;5.
   Web of Science ®Google Scholar
• Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am. 2008 Nov;92(6):1377–1390.
   PubMed Web of Science ®Google Scholar
• Dengue GD. Urbanization and globalization: The unholy TRinity of the 21(st) century. Trop Med Health. 2011 Dec;39(4 Suppl):3–11.
   Google Scholar
• Mendonça HF, Ferreira AL, Santos CB, et al. Breeding sites of Aedes aegypti in metropolitan vacant lots in greater vitória, state of espírito santo, Brazil. Rev Soc Bras Med Trop. 2011 Mar-Apr;44(2):243–246.
   PubMed Web of Science ®Google Scholar
• Stanaway JD, Shepard DS, Undurraga EA, et al. The global burden of dengue: an analysis from the global burden of disease study 2013. Lancet Infect Dis. 2016;16(6):712–723.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013 Apr 25;496(7446):504–507.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Communicable disease control P, and eradication parasitic diseases and vector control. strengthening implementation of the global strategy for dengue fever/ Dengue Haemorrhagic Fever Prevention and control geneva. Switzerland: WHO HQ; 2000.
   Google Scholar
• WHOROfS-EA. Comprehensive Guideline for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Revised and expanded edition. WHO Regional Office for South-East Asia.; 2011.
   Google Scholar
• Rothman AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011 Jul 15;11(8):532–543.
   PubMed Web of Science ®Google Scholar
• Guzman MG, Harris E. Dengue. Lancet. 2015 Jan 31;385(9966):453–465.
   PubMed Web of Science ®Google Scholar
• Hahn YS, Galler R, Hunkapiller T, et al. Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses. Virology. 1988 Jan;162(1):167–180.
   PubMed Web of Science ®Google Scholar
• Hahn CS, Hahn YS, Rice CM, et al. Conserved elements in the 3’ untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol. 1987 Nov 05;198(1):33–41.
   PubMed Web of Science ®Google Scholar
• Jenkins GM, Rambaut A, Pybus OG, et al. Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol. 2002 Feb;54(2):156–165.
   PubMed Web of Science ®Google Scholar
• Ruggli N, Rice CM. Functional cDNA clones of the flaviviridae: strategies and applications. Adv Virus Res. 1999;53:183–207.
   PubMed Web of Science ®Google Scholar
• Ward R D, Andrew D. Reverse genetics and the study of dengue virus. Future Virol. 2008;3:279–290.
   Web of Science ®Google Scholar
• Douam F, Ploss A. The use of humanized mice for studies of viral pathogenesis and immunity. Curr Opin Virol. 2018;29:62–71.
   PubMed Web of Science ®Google Scholar
• Frias-Staheli N, Dorner M, Marukian S, et al. Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing. J Virol. 2014 Feb;88(4):2205–2218.
   PubMed Web of Science ®Google Scholar
• Bente DA, Melkus MW, Garcia JV, et al. Dengue fever in humanized NOD/SCID mice. J Virol. 2005 Nov;79(21):13797–13799.
   PubMed Web of Science ®Google Scholar
• Mota J, Rico-Hesse R. Dengue virus tropism in humanized mice recapitulates human dengue fever. PLoS One. 2011;6(6):e20762.
   PubMed Web of Science ®Google Scholar
• Sridharan A, Chen Q, Tang KF, et al. Inhibition of megakaryocyte development in the bone marrow underlies dengue virus-induced thrombocytopenia in humanized mice. J Virol. 2013 Nov;87(21):11648–11658.
   PubMed Web of Science ®Google Scholar
• Douam F, Ziegler CGK, Hrebikova G, et al. Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses. Nat Commun. 2018;9(1):5031.
   PubMed Web of Science ®Google Scholar
• Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002 Dec;76(24):13001–13014.
   PubMed Web of Science ®Google Scholar
• Tamura T, Fukuhara T, Uchida T, et al. Characterization of recombinant Flaviviridae viruses possessing a small Reporter Tag. J Virol. 2018 Jan 15;92(2):e01582–17.
   PubMed Web of Science ®Google Scholar
• Hadfield J, Megill C, Bell SM, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34(23):4121–4123.
   PubMed Web of Science ®Google Scholar
• Edgar RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32(5):1792–1797.
   PubMed Web of Science ®Google Scholar
• Waggoner JJ, Abeynayake J, Sahoo MK, et al. Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J Clin Microbiol. 2013 Jul;51(7):2172–2181.
   PubMed Web of Science ®Google Scholar
• Pearson T, Shultz LD, Miller D, et al. Non-obese diabetic-recombination activating gene-1 (NOD-Rag1 null) interleukin (IL)-2 receptor common gamma chain (IL2r gamma null) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol. 2008 Nov;154(2):270–284.
   PubMed Web of Science ®Google Scholar
• Brinton MA, Fernandez AV, Dispoto JH. The 3'-nucleotides of flavivirus genomic RNA form a conserved secondary structure. Virology. 1986 Aug;153(1):113–121.
   PubMed Web of Science ®Google Scholar
• Proutski V, Gould EA, Holmes EC. Secondary structure of the 3’ untranslated region of flaviviruses: similarities and differences. Nucleic Acids Res. 1997 Mar 15;25(6):1194–1202.
   PubMed Web of Science ®Google Scholar
• Burke DSMT. Flaviviruses. fields virology. In: Knipe DM, Howley PM, 1, 4th ed Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1043–1125.
   Google Scholar
• Chambers TJ, Hahn CS, Galler R, et al. Flavivirus genome organization, expression, and replication. Annu Rev Microbiol. 1990;44:649–688.
   PubMed Web of Science ®Google Scholar
• Quan J, Tian J. Circular polymerase extension cloning of complex gene libraries and pathways. PLoS One. 2009 Jul 30;4(7):e6441.
   PubMed Web of Science ®Google Scholar
• Edmonds J, van Grinsven E, Prow N, et al. A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity. J Virol. 2013 Feb;87(4):2367–2372.
   PubMed Web of Science ®Google Scholar
• Setoh YX, Prow NA, Peng N, et al. De novo generation and characterization of New Zika virus isolate using sequence data from a microcephaly case. mSphere. 2017 May-Jun;2(3):e00190–17.
   PubMed Web of Science ®Google Scholar
• Tamura T, Igarashi M, Enkhbold B, et al. Dynamics of reporter. J Virol. 2019 Oct 29;93(22):e01191–19.
   PubMed Web of Science ®Google Scholar
• Srikiatkhachorn A, Wichit S, Gibbons RV, et al. Dengue viral RNA levels in peripheral blood mononuclear cells are associated with disease severity and preexisting dengue immune status. PLoS One. 2012;7(12):e51335.
   PubMed Web of Science ®Google Scholar
• Baclig MO, Gervacio LT, Suarez LA, et al. Flow cytometric analysis of dengue virus-infected cells in peripheral blood. Southeast Asian J Trop Med Public Health. 2010 Nov;41(6):1352–1358.
   PubMed Web of Science ®Google Scholar
• King AD, Nisalak A, Kalayanrooj S, et al. B cells are the principal circulating mononuclear cells infected by dengue virus. Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):718–728.
   PubMedGoogle Scholar
• Blackley S, Kou Z, Chen H, et al. Primary human splenic macrophages, but not T or B cells, are the principal target cells for dengue virus infection in vitro. J Virol. 2007 Dec;81(24):13325–13334.
   PubMed Web of Science ®Google Scholar
• Kou Z, Quinn M, Chen H, et al. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J Med Virol. 2008 Jan;80(1):134–146.
   PubMed Web of Science ®Google Scholar
• La Russa VF, Innis BL. Mechanisms of dengue virus-induced bone marrow suppression. Baillieres Clin Haematol. 1995 Mar;8(1):249–270.
   PubMed Web of Science ®Google Scholar
• Tian Y, Grifoni A, Sette A, et al. Human T cell response to dengue virus infection. Front Immunol. 2019;10:2125.
   PubMed Web of Science ®Google Scholar
• Miller JD, van der Most RG, Akondy RS, et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity. 2008 May;28(5):710–722.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Pearson T, Friberg H, et al. Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice. PLoS One. 2009 Oct 05;4(10):e7251.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Pazoles P, Woda M, et al. Enhanced humoral and HLA-A2-restricted dengue virus-specific T-cell responses in humanized BLT NSG mice. Immunology. 2012 Jul;136(3):334–343.
   PubMed Web of Science ®Google Scholar
• Parajuli P, Mosley RL, Pisarev V, et al. Flt3 ligand and granulocyte-macrophage colony-stimulating factor preferentially expand and stimulate different dendritic and T-cell subsets. Exp Hematol. 2001 Oct;29(10):1185–1193.
   PubMed Web of Science ®Google Scholar
• Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7–16.
   PubMed Web of Science ®Google Scholar
• Kuruvilla JG, Troyer RM, Devi S, et al. Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology. 2007 Dec 05;369(1):143–152.
   PubMed Web of Science ®Google Scholar
• Ojha A, Nandi D, Batra H, et al. Platelet activation determines the severity of thrombocytopenia in dengue infection. Sci Rep. 2017;7:41697.
   PubMed Web of Science ®Google Scholar
• Chandele A, Sewatanon J, Gunisetty S, et al. Characterization of human CD8 T cell responses in dengue virus-infected patients from India. J Virol. 2016 Dec 15;90(24):11259–11278.
   PubMed Web of Science ®Google Scholar
• Dung NT, Duyen HT, Thuy NT, et al. Timing of CD8+ T cell responses in relation to commencement of capillary leakage in children with dengue. J Immunol. 2010 Jun 15;184(12):7281–7287.
   PubMed Web of Science ®Google Scholar
• de Matos AM, Carvalho KI, Rosa DS, et al. CD8+ t lymphocyte expansion, proliferation and activation in dengue fever. PLoS Negl Trop Dis. 2015 Feb;9(2):e0003520.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Smith K, Ramirez A, et al. Dengue virus infection induces broadly cross-reactive human IgM antibodies that recognize intact virions in humanized BLT-NSG mice. Exp Biol Med (Maywood). 2015 Jan;240(1):67–78.
   PubMed Web of Science ®Google Scholar